scholarly article | Q13442814 |
P2093 | author name string | M John | |
S B Calderwood | |||
E T Ryan | |||
A A Luciano | |||
K E Klose | |||
T I Crean | |||
K P Killeen | |||
S K Kochi | |||
P2860 | cites work | Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I | Q24651553 |
Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development | Q28485732 | ||
A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR | Q29615324 | ||
Emergence of a new cholera pandemic: molecular analysis of virulence determinants in Vibrio cholerae O139 and development of a live vaccine prototype | Q30420490 | ||
Differential regulation of multiple flagellins in Vibrio cholerae | Q33722821 | ||
In vivo expression and immunoadjuvancy of a mutant of heat-labile enterotoxin of Escherichia coli in vaccine and vector strains of Vibrio cholerae | Q34000827 | ||
Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory | Q34225394 | ||
Development of a germfree mouse model of Vibrio cholerae infection. | Q35526942 | ||
Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains | Q35548775 | ||
Protective immunity against Clostridium difficile toxin A induced by oral immunization with a live, attenuated Vibrio cholerae vector strain | Q35551627 | ||
Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae | Q35552261 | ||
Simultaneous prevention of glutamine synthesis and high-affinity transport attenuates Salmonella typhimurium virulence | Q35567150 | ||
CTX genetic element encodes a site-specific recombination system and an intestinal colonization factor. | Q36262564 | ||
Identification of an iron-regulated virulence determinant in Vibrio cholerae, using TnphoA mutagenesis. | Q36975350 | ||
Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector | Q36989608 | ||
Isogenic P-fimbrial deletion mutants of pyelonephritogenic Escherichia coli: the role of alpha Gal(1-4) beta Gal binding in virulence of a wild-type strain. | Q38315664 | ||
Distinct roles of an alternative sigma factor during both free-swimming and colonizing phases of the Vibrio cholerae pathogenic cycle | Q47956624 | ||
Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR. | Q54378370 | ||
Allelic exchange in Escherichia coli using the Bacillus subtilis sacB gene and a temperature-sensitive pSC101 replicon | Q54696474 | ||
An nptI-sacB-sacR cartridge for constructing directed, unmarked mutations in gram-negative bacteria by marker exchange-eviction mutagenesis. | Q54769200 | ||
Development of a live, oral, attenuated vaccine against El Tor cholera | Q57924437 | ||
Initial clinical studies of CVD 112 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge | Q57924808 | ||
Duration of infection-derived immunity to cholera | Q70831304 | ||
Use of the Vibrio cholerae irgA gene as a locus for insertion and expression of heterologous antigens in cholera vaccine strains | Q72746081 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Vibrio cholerae | Q160821 |
attenuated vaccine | Q1810913 | ||
P304 | page(s) | 221-226 | |
P577 | publication date | 2000-01-01 | |
P1433 | published in | Infection and Immunity | Q6029193 |
P1476 | title | Development of a DeltaglnA balanced lethal plasmid system for expression of heterologous antigens by attenuated vaccine vector strains of Vibrio cholerae | |
P478 | volume | 68 |
Q44533423 | A Vibrio cholerae serogroup O1 vaccine candidate against CTX ET Phi infection |
Q52684483 | A self-assembling whole cell vaccine antigen presentation platform. |
Q35193532 | Advances in the development of bacterial vector technology |
Q33769332 | Antibiotic-free plasmid stabilization by operator-repressor titration for vaccine delivery by using live Salmonella enterica Serovar typhimurium |
Q27028105 | Antibiotic-free selection in biotherapeutics: now and forever |
Q57915185 | Attenuated Bacterial Vaccines |
Q39108492 | Comparison of mucosal and systemic humoral immune responses after transcutaneous and oral immunization strategies |
Q36045133 | Construction and Evaluation of a Safe, Live, Oral Vibrio cholerae Vaccine Candidate, IEM108 |
Q46652410 | Construction and evaluation of a O139 Vibrio cholerae vaccine candidate based on a hemA gene mutation |
Q50854404 | Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli. |
Q41418787 | Construction and screening of attenuated ΔphoP/Q Salmonella typhimurium vectored plague vaccine candidates |
Q35896020 | Enteric pathogens as vaccine vectors for foreign antigen delivery |
Q37002887 | Exploiting cholera vaccines as a versatile antigen delivery platform |
Q34003489 | In vitro and in vivo analyses of constitutive and in vivo-induced promoters in attenuated vaccine and vector strains of Vibrio cholerae |
Q31060871 | In vivo phage display to identify M cell-targeting ligands |
Q36600341 | Live attenuated oral cholera vaccines |
Q36653379 | New technologies in developing recombinant attenuated Salmonella vaccine vectors |
Q33768314 | Novel antibiotic-free plasmid selection system based on complementation of host auxotrophy in the NAD de novo synthesis pathway |
Q34003405 | Optimizing the germfree mouse model for in vivo evaluation of oral Vibrio cholerae vaccine and vector strains |
Q30168445 | Outer membrane proteins as surface display systems |
Q30363424 | Prolonged colonization of mice by Vibrio cholerae El Tor O1 depends on accessory toxins |
Q27011946 | Salmonella as a vaccine delivery vehicle |
Q36898558 | Use of mchI encoding immunity to the antimicrobial peptide microcin H47 as a plasmid selection marker in attenuated bacterial live vectors |
Search more.